Literature DB >> 19636893

NMR assignments of the sylvatic dengue 1 virus envelope protein domain III.

David E Volk1, Kurtis M Anderson, Sai H A Gandham, Fiona J May, Li Li, David W C Beasley, Alan D T Barrett, David G Gorenstein.   

Abstract

Nearly complete backbone and side chain resonance assignments have been obtained for the third domain, residues M289-K400, of the envelope protein from the sylvatic strain (P72-1244) of the dengue 1 virus, containing mutations N336S and E370K, using double- and triple-resonance spectroscopy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19636893      PMCID: PMC2593834          DOI: 10.1007/s12104-008-9109-5

Source DB:  PubMed          Journal:  Biomol NMR Assign        ISSN: 1874-270X            Impact factor:   0.746


  15 in total

Review 1.  Flavivirus structure and membrane fusion.

Authors:  Franz X Heinz; Steven L Allison
Journal:  Adv Virus Res       Date:  2003       Impact factor: 9.937

2.  Solution structure and antibody binding studies of the envelope protein domain III from the New York strain of West Nile virus.

Authors:  David E Volk; David W C Beasley; Deborah A Kallick; Michael R Holbrook; Alan D T Barrett; David G Gorenstein
Journal:  J Biol Chem       Date:  2004-06-09       Impact factor: 5.157

3.  Crystal structure of west nile virus envelope glycoprotein reveals viral surface epitopes.

Authors:  Ryuta Kanai; Kalipada Kar; Karen Anthony; L Hannah Gould; Michel Ledizet; Erol Fikrig; Wayne A Marasco; Raymond A Koski; Yorgo Modis
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

4.  Solution structure of the envelope protein domain III of dengue-4 virus.

Authors:  David E Volk; Yi-Chien Lee; Xin Li; Varatharasa Thiviyanathan; Gregory D Gromowski; Li Li; Ashley R Lamb; David W C Beasley; Alan D T Barrett; David G Gorenstein
Journal:  Virology       Date:  2007-03-29       Impact factor: 3.616

5.  NMR assignments of the yellow fever virus envelope protein domain III.

Authors:  David E Volk; Sai H A Gandham; Fiona J May; Anjenique Anderson; Alan D T Barrett; David G Gorenstein
Journal:  Biomol NMR Assign       Date:  2007-05-09       Impact factor: 0.746

6.  Crystal structure of the West Nile virus envelope glycoprotein.

Authors:  Grant E Nybakken; Christopher A Nelson; Beverly R Chen; Michael S Diamond; Daved H Fremont
Journal:  J Virol       Date:  2006-09-20       Impact factor: 5.103

7.  A ligand-binding pocket in the dengue virus envelope glycoprotein.

Authors:  Yorgo Modis; Steven Ogata; David Clements; Stephen C Harrison
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-20       Impact factor: 11.205

8.  1H, 13C and 15N resonance assignments for domain III of the West Nile virus envelope protein.

Authors:  David E Volk; Deborah A Kallick; Michael R Holbrook; David W C Beasley; Alan D T Barrett; David G Gorenstein
Journal:  J Biomol NMR       Date:  2004-07       Impact factor: 2.835

9.  A novel approach for sequential assignment of 1H, 13C, and 15N spectra of proteins: heteronuclear triple-resonance three-dimensional NMR spectroscopy. Application to calmodulin.

Authors:  M Ikura; L E Kay; A Bax
Journal:  Biochemistry       Date:  1990-05-15       Impact factor: 3.162

10.  Structural basis of a flavivirus recognized by its neutralizing antibody: solution structure of the domain III of the Japanese encephalitis virus envelope protein.

Authors:  Kuen-Phon Wu; Chih-Wei Wu; Ya-Ping Tsao; Ting-Wei Kuo; Yuan-Chao Lou; Cheng-Wen Lin; Suh-Chin Wu; Jya-Wei Cheng
Journal:  J Biol Chem       Date:  2003-09-02       Impact factor: 5.157

View more
  3 in total

1.  Thioaptamers targeting dengue virus type-2 envelope protein domain III.

Authors:  Sai Hari A Gandham; David E Volk; Ganesh L R Lokesh; Muniasamy Neerathilingam; David G Gorenstein
Journal:  Biochem Biophys Res Commun       Date:  2014-09-26       Impact factor: 3.575

2.  Simplifying complex sequence information: a PCP-consensus protein binds antibodies against all four Dengue serotypes.

Authors:  David M Bowen; Jessica A Lewis; Wenzhe Lu; Catherine H Schein
Journal:  Vaccine       Date:  2012-07-31       Impact factor: 3.641

3.  Rational engineering of a human anti-dengue antibody through experimentally validated computational docking.

Authors:  Luca Simonelli; Mattia Pedotti; Martina Beltramello; Elsa Livoti; Luigi Calzolai; Federica Sallusto; Antonio Lanzavecchia; Luca Varani
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.